VLP Therapeutics (United States)
- Research works
- 23 ▲ 26% vs 2013–17
- Citations
- 436 19.0 per fractional work
- Top-10% rate
- 19.1% record average 16.5%
- Open access
- 57% world 28%
Not ranked overall: VLP Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 20.2×. Every wedge is a field page.
- Immunology and Microbiology 20.2×
- Health Professions 2.7×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Social Sciences 2.0×
- Computer Science 1.5×
- Medicine 1.1×
- Economics, Econometrics and Finance 0.7×
- Materials Science 0.2×
- Agricultural and Biological Sciences 0.1×
Which keywords describe research at VLP Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunity, Vaccine, Epidemiology, Inflammation, Metabolism, Gene Therapy, Tumor Targeting and Immunotherapy.
- European Union Cohesion Policy
- Immunotherapy
- Metabolism
- Cancer
- Inflammation
- Epidemiology
- Immunity
- Vaccine
- Gene Therapy
- Tumor Targeting
- Smart Specialization
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 11 words, with their numbers
- Epidemiology2▲ 2.5×15 topics
- Inflammation2▲ 3.4×5 topics
- Immunity2▲ 22×4 topics
- Cancer1▲ 4.1×3 topics
- Vaccine1▲ 15×7 topics
- Metabolism1▲ 7.8×2 topics
- Gene Therapy1▲ 18×2 topics
- Immunotherapy1▲ 7.0×3 topics
- Tumor Targeting1▲ 35×3 topics
- European Union Cohesion Policy1▲ 174×1 topic
- Smart Specialization1▲ 117×1 topic
Which research topics does VLP Therapeutics (United States) publish most on?
By volume in 2022–2025: Immune cells in cancer, Lymphoma Diagnosis and Treatment, Cell Adhesion Molecules Research and Employment and Welfare Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune cells in cancer Immunology 1 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 3 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 4 Employment and Welfare Studies General Health Professions 0 works
- 5 Global Educational Policies and Reforms Political Science and International Relations 0 works
- 6 Parallel Computing and Optimization Techniques Hardware and Architecture 0 works
- 7 Youth Development and Social Support Safety Research 0 works
- 8 International Labor and Employment Law Political Science and International Relations 0 works
- 9 Social and Educational Sciences Education 0 works
- 10 Cloud Computing and Resource Management Information Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has VLP Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 26% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- NIST Center for Neutron Research
- Material Measurement Laboratory
- Center for Nanoscale Science and Technology
- Information Technology Laboratory
- Robotic Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.